LORANTIS
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation. The company is based in Cambridge, United Kingdom.
LORANTIS
Industry:
Health Care Health Diagnostics Medical Device
Founded:
1998-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.lorantis.co.uk
Status:
Closed
Contact:
+4401223702500
Email Addresses:
[email protected]
Total Funding:
44.01 M USD
Technology used in webpage:
Domain Not Resolving
Investors List
Quester Capital
Quester Capital investment in Series C - Lorantis
JPMorgan Partners
JPMorgan Partners investment in Series C - Lorantis
Schroder Ventures
Schroder Ventures investment in Series C - Lorantis
Wellcome Trust
Wellcome Trust investment in Series C - Lorantis
Abingworth
Abingworth investment in Series C - Lorantis
Apax Partners
Apax Partners investment in Series C - Lorantis
